BIO: Conflicting views on US healthcare reforms
This article was originally published in Scrip
Executive Summary
The US is likely to embrace a government-led, or public plan, as part of the revolution of the country's healthcare framework, a panel of political leaders agreed at the Biotechnology Industry Organization's annual meeting. A quartet of prominent figures from both main political parties also said that healthcare costs must be reined in and some level of private sector insurance retained.